Skip to main content

Table 1 Needle biopsy diagnosis* compared to results of surgical biopsy.

From: Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program

Needle Biopsy Diagnosis*

N =

Surgical Biopsy Diagnosis

  

Non-malignant‡

DCIS

Invasive Malignancy

ADH

36

19(53%) §

13(36%)

4(11%)

ALH

4

4(100%)

  

LCIS

5

3(60%)

1(20%)

1 (20%)

Radial Scar †

18

18(100%)||

  

FEA

5

3(60%)

1(20%)

1 (20%)

MLL

3

3(100%) ¶

  

Papillary lesion

23 **

21(91%)

1(4%) ††

1(4%) ‡‡

Total

94

71(76%)

16(17%)

7(7%)

  1. * biopsy type = Vacuum assisted large core stereotactic guided core needle biopsy (VALCS) unless stated otherwise
  2. † Radial Scar represents both radial scars and complex sclerosing lesions.
  3. ‡ Non-Malignant lesions include borderline lesions and benign lesions (ductal hyperplasia with no atypia, sclerosing adenosis, fibroadenoma, fibrocystic change and scar tissue).
  4. § biopsy type on one lesion by Ultrasound guided core needle biopsy (USCNB)
  5. || biopsy type on four lesions by USCNB
  6. ¶ biopsy type on one lesion USCNB and on two lesions Fine needle biopsy (FNB)
  7. ** biopsy type on seven lesions USCNB and on eight lesions FNB
  8. †† biopsy type VALCS only
  9. ‡‡ biopsy type FNB only
  10. ADH = Atypical ductal hyperplasia; ALH = Atypical lobular hyperplasia; FEA = Flat epithelial atypia; LCIS = Lobular carcinoma in situ; MLL = Mucocoele-like lesions;
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us